WAYNE, Pa., March 12, 2019 /PRNewswire-PRWeb/ -- Facet Life Sciences, a leading provider of development software and
Effective March 1, 2019, Dr. Lisa Jenkins VanLuvanee has been promoted to Chief Operating Officer. Dr. Jenkins VanLuvanee most recently served as Vice President of Research and Development where she held leadership responsibility for Facet's entire services team. She joined Facet in 2012, bringing a wealth of practical experience leading regulatory submission projects, developing and executing regulatory strategies and mentoring cross-functional teams.
In addition to her current responsibilities, in her new role, Dr. Jenkins VanLuvanee will be responsible for all customer-facing operations for both services and technology clients. Dr. Jenkins VanLuvanee commented, "I am looking forward to this new opportunity to help more small and mid-size teams progress their development programs in smart, innovative, and cost-effective ways. Regulatory expertise and document management capabilities are essential for product development teams. I am eager to ensure continued momentum behind our services and technology solutions."
Ken VanLuvanee, President and CEO, Facet Life Sciences, commented, "Dr. Jenkins VanLuvanee has accepted responsibility for most aspects of Facet's client-facing operations. Today's announcement reflects her success to date and our confidence in her ability to maintain growth across the services and technology segments of our business."
About Facet Life Sciences Facet Life Sciences is the leading provider of innovative development solutions (software and services) designed to help small teams get to and through the FDAİ. Our Product Development Champions deliver expert nonclinical, CMC, and clinical regulatory services using cutting-edge technologies that speed product R&D efforts. Facet teams create and manage critical development documentation for some of the industry's fastest growing, most innovative life sciences companies.
SOURCE Facet Life Sciences
Subscribe to our Free Newsletters!